|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1050 K STREET, NW, #800 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
|
5. Senate ID# 16293-12
|
||||||||
|
6. House ID# 314610000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Sarah J. Walsh, Vice President, Federal Government Relations Tax & Pharmaceuticals |
Date | 10/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S. 515 Patent Reform Act of 2009 and the Manager's Amendment
H.R. 1250 Patent Reform Act of 2009
S. 369 Preserve Access to Affordable Generics Act
H.R. 1706 Protecting Consumer Access to Generic Drugs Act of 2009
H.R. 5322 Patent and Trademark Office Funding Stabilization Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
John |
Del Giorno |
|
|
|
Sarah |
Walsh |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Gary |
Heimberg |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 759 Food and Drug Administration Globalization Act of 2009
S. 882 Drug and Device Accountability Act of 2009
H.R. 1346 Medical Device Safety Act of 2009
S. 540 Medical Device Safety Act of 2009
H.R. 1508 Sunshine in Litigation Act of 2009
S.537 Sunshine in Litigation Act of 2009
S. 386 Fraud Enforcement and Recovery Act of 2009
S. 458 False Claims Act Clarification Act of 2009
H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009
S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009
S. 301 Physician Payments Sunshine Act of 2009
H.R. 1166 E-fencing Enforcement Act of 2009
H.R. 1173 Organized Retail Crime Act of 2009
S. 470 Combating Organized Retail Crime Act of 2009
H.R. 1788 False Claims Act Correction Act of 2009
H.R. 2892 Department of Homeland Security Appropriations, 2010 - provisions pertaining to Importation.
H.R. 3202 Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment
S. 1504 Notice Pleading Restoration Act of 2009
S. 1679 Affordable Health Choices Act
H.R. 3200 America's Affordable Health Choices Act of 2009
S. 1796 America's Affordable Health Choices Act of 2009
H.R. 3590 Patient Protection and Affordable Care Act
America's Healthy Future Act of 2009
H.R. 3974 Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
H.R. 2596 No Child Left Unimmunized Against Influenza Act of 2009
S. 2964 Strengthening Program Integrity and Accountability in Health Care Act
S. 3002 Dietary Supplement Safety Act of 2010
H.R. 4872 Health Care and Education Affordability Reconciliation Act
H.R. 5516 Access to Appropriate Immunizations for Veterans Act of 2010
H.R. 5503 Securing Protections for the Injured from Limitations on Liability Act
H.R. 4899 Supplemental Appropriations Act, 2010 - provisions pertaining to Bio-defense funding and the
Ryan White CARE Act
S. 3686 Fiscal Year 2011 Labor HHS Appropriations, all provisions pertaining to the Ryan White CARE Act as well as
related House Fiscal Year 2011 Labor-HHS Appropriations Ryan White CARE Act provisions
H.R. 5923 Patients Freedom to Choose Act, reimbursement of OTC drugs under Flexible and Health Savings accounts
S. 3673 Patients Freedom to Choose Act, reimbursement of OTC drugs under Flexible and Health Savings accounts
S. 3397 Secure and Responsible Drug Disposal Act, drug safety
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
John |
Del Giorno |
|
|
|
Sarah |
Walsh |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Gary |
Heimberg |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act of 2009
S. 726 Promoting Innovation and Access to Life-saving Medicine Act of 2009
H.R. 1548 The Pathway for Biosimilars Act of 2009
Food and Drug Administration's oversight and review of drug safety
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
John |
Del Giorno |
|
|
|
Sarah |
Walsh |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Gary |
Heimberg |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S.1003 Immunization Improvement Act of 2009
HR. 323 Comprehensive Insurance Coverage of Childhood Immunization Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
John |
Del Giorno |
|
|
|
Sarah |
Walsh |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Gary |
Heimberg |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 422 To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
John |
Del Giorno |
|
|
|
Sarah |
Walsh |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Gary |
Heimberg |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
H.R. 5175 Democracy is Strengthened by Casting Light on Spending in Elections Act
S. 3295 Democracy is Strengthened by Casting Light on Spending in Elections Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
John |
Del Giorno |
|
|
|
Sarah |
Walsh |
|
|
|
William |
Schuyler |
|
|
|
Kimberly |
Williams |
|
|
|
Gary |
Heimberg |
|
|
|
John |
Herzog |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |